4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-23-000066
Chief Executive Officer sold 25,066 shares at $39.49 ($989,947)
- Chief Executive Officer acquired 57,267 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Monia Brett P · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 1 in the form | +57,267 | 145,929 | D | ||
| 2023-01-18 | Sale : show line 2 in the form | −25,066 | $39.49 | $989,947 | 120,863 | D |
| Open-market sales · 25,066 sh · avg $39.49 · $989,947 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-17 | Exercise or conversion : show line 3 in the form Restricted Stock Unit | −57,267 | $0.00 | 57,267 | 176,861 | D |
Loading xslF345X03/edgardoc.xml…